MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 4 filers reported holding MEDICINES CO in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $16,995,000 | +9.5% | 200,083 | -35.5% | 0.02% | 0.0% |
| Q3 2019 | $15,519,000 | +40.4% | 310,381 | +2.4% | 0.02% | +42.9% |
| Q2 2019 | $11,055,000 | +31.3% | 303,131 | +0.6% | 0.01% | +27.3% |
| Q1 2019 | $8,420,000 | +72.9% | 301,260 | +18.4% | 0.01% | +57.1% |
| Q4 2018 | $4,871,000 | -12.6% | 254,492 | +36.6% | 0.01% | 0.0% |
| Q3 2018 | $5,572,000 | -19.9% | 186,297 | -1.7% | 0.01% | -22.2% |
| Q2 2018 | $6,957,000 | -11.5% | 189,558 | -20.6% | 0.01% | -10.0% |
| Q1 2018 | $7,862,000 | +35.1% | 238,665 | +12.1% | 0.01% | +42.9% |
| Q4 2017 | $5,819,000 | -2.6% | 212,842 | +32.0% | 0.01% | -12.5% |
| Q3 2017 | $5,974,000 | -31.8% | 161,297 | -30.0% | 0.01% | -33.3% |
| Q2 2017 | $8,764,000 | -3.7% | 230,558 | +23.8% | 0.01% | 0.0% |
| Q1 2017 | $9,104,000 | +155.2% | 186,176 | +77.1% | 0.01% | +140.0% |
| Q4 2016 | $3,568,000 | +21.6% | 105,140 | +35.2% | 0.01% | +25.0% |
| Q3 2016 | $2,935,000 | +17.2% | 77,772 | +4.4% | 0.00% | 0.0% |
| Q2 2016 | $2,504,000 | +11.8% | 74,472 | +5.6% | 0.00% | +33.3% |
| Q1 2016 | $2,240,000 | -14.8% | 70,507 | +0.2% | 0.00% | -25.0% |
| Q4 2015 | $2,629,000 | +11.4% | 70,394 | +13.2% | 0.00% | 0.0% |
| Q3 2015 | $2,361,000 | -44.2% | 62,200 | -57.9% | 0.00% | -33.3% |
| Q2 2015 | $4,229,000 | +13.7% | 147,802 | +11.4% | 0.01% | +20.0% |
| Q1 2015 | $3,718,000 | +1.9% | 132,700 | +0.6% | 0.01% | 0.0% |
| Q4 2014 | $3,650,000 | +24.0% | 131,900 | 0.0% | 0.01% | +25.0% |
| Q3 2014 | $2,944,000 | -33.8% | 131,900 | -13.8% | 0.00% | -42.9% |
| Q2 2014 | $4,449,000 | -23.2% | 153,100 | -24.9% | 0.01% | -22.2% |
| Q1 2014 | $5,791,000 | -24.8% | 203,750 | +2.2% | 0.01% | -25.0% |
| Q4 2013 | $7,703,000 | +21.6% | 199,450 | +5.5% | 0.01% | +9.1% |
| Q3 2013 | $6,337,000 | +57.4% | 189,050 | +44.4% | 0.01% | +57.1% |
| Q2 2013 | $4,026,000 | – | 130,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
| Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
| Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
| Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
| BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
| Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
| HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
| Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
| Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
| THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |